$6.16
-0.61-9.01%
At close: Aug 28, 5:00 PM EST
$6.50
0.345.52%
After Hours: Aug 28, 9:22 AM EST
Clinuvel Pharmaceuticals Ltd (CUVL) Stock Price, Quote, News & History
CUVLNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Clinuvel Pharmaceuticals (CUVL) stock?
You can purchase shares of Clinuvel Pharmaceuticals (NASDAQ:CUVL) through any online brokerage.
Who are Clinuvel Pharmaceuticals (CUVL) competitors?
Other companies in Clinuvel Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Clinuvel Pharmaceuticals (CUVL) stock?
There is no analysis for Clinuvel Pharmaceuticals to provide a consensus price target.
What is the current price for Clinuvel Pharmaceuticals (CUVL)?
The stock price for Clinuvel Pharmaceuticals (NASDAQ: CUVL) is $6.5 last updated August 28, 2026 at 9:22 AM EDT.
Does Clinuvel Pharmaceuticals (CUVL) pay a dividend?
There are no upcoming dividends for Clinuvel Pharmaceuticals.
When is Clinuvel Pharmaceuticals (NASDAQ:CUVL) reporting earnings?
Clinuvel Pharmaceuticals does not have any upcoming earnings scheduled.
Is Clinuvel Pharmaceuticals (CUVL) going to split?
There is no upcoming split for Clinuvel Pharmaceuticals.
What sector and industry does Clinuvel Pharmaceuticals (CUVL) operate in?
Clinuvel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
